In the aftermath of the mass shooting at a Florida high school last week that killed 17 students and adults, 6 medical organizations are calling on President Trump and Congress to treat gun violence as a national public health epidemic amid a press report that attitudes are loosening on Capitol Hill about putting more research money into the issue.
In the aftermath of the mass shooting at a Florida high school last week that killed 17 students and adults, 6 medical organizations are calling on President Donald Trump and Congress to treat gun violence as a national public health epidemic amid a press report that attitudes are loosening on Capitol Hill about putting more research money into the issue.
The statement, issued Friday, came from the American Academy of Family Physicians, the American Academy of Pediatrics, the American College of Physicians, the American Congress of Obstetricians and Gynecologists, the American Osteopathic Association, and the American Psychiatric Association. Collectively, they represent 450,000 physicians and medical students.
The organizations are asking for the funding of “appropriate research at the [CDC] as part of the FY 2018 omnibus spending package.” They also are calling for gun control measures on assault rifles, or “large-capacity magazines and firearms with features designed to increase their rapid and extended killing capacity.”
The American Medical Association has also called for action in Washington, DC, about gun violence as a public health issue.
Last week, HHS Secretary Alex Azar said he would be open to the CDC researching the causes of gun violence. The Hill on Monday reported that some House Republicans were supportive of his remarks, including Reps. Leonard Lance (New Jersey), Phil Roe (Tennessee), Mark Walker (North Carolina), and Bob Goodlatte (Virginia).
The current restrictions were put in place as part of a federal spending bill in 1996 after lobbying by groups like the National Rifle Association. The provision states that "None of the funds made available in this title may be used, in whole or in part, to advocate or promote gun control.”
Azar said last week that it was only the advocacy part of the provision he was opposed to.
The Hill reported that although the wording does not explicitly ban research into gun violence, Democrats and some public health researchers argue that it has had the same chilling effect on such research for over 20 years.
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More